NovoCure Ltd — Director's Dealing 2019

Jun 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-06-11

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-11	Ordinary Shares	M	16835	$14.37	Acquired	275146	Direct
2019-06-11	Ordinary Shares	S	15985	$54.71	Disposed	259161	Direct
2019-06-11	Ordinary Shares	S	850	$55.425	Disposed	258311	Direct
2019-06-12	Ordinary Shares	M	30436	$14.37	Acquired	288747	Direct
2019-06-12	Ordinary Shares	S	12233	$54.886	Disposed	276514	Direct
2019-06-12	Ordinary Shares	S	18203	$55.735	Disposed	258311	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-11	Options to Buy Ordinary Shares	$14.37	M	16835	Disposed	2025-02-23	Ordinary Shares (16835)	Direct
2019-06-12	Options to Buy Ordinary Shares	$14.37	M	30436	Disposed	2025-02-23	Ordinary Shares (30436)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

F2: On June 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 15,985 shares in multiple trades at prices ranging from $54.37 to $55.35. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On June 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 850 shares in multiple trades at prices ranging from $55.41 to $55.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On June 12, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 12,233 shares in multiple trades at prices ranging from $54.39 to $55.38. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: On June 12, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 18,203 shares in multiple trades at prices ranging from $55.40 to $56.10. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F6: Fully vested and currently exercisable as of the date hereof.